Author

M. J. Boulanger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 2 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. K. Snyder· 1 shared A. Kelsen· 1 shared B. Martorelli di Genova· 1 shared C. J. Powell· 1 shared C. Powell· 1 shared D. M. Warshaw· 1 shared E. Wehri· 1 shared G. Adedoyin· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. K. Snyder

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 17, 2022

Toxoplasma surface coat protein TgSRS57 (TgSAG3) regulates complement deposition, Factor H recruitment, and promotes parasite persistence

V. Pszenny, P. M. Sikorski, R. Ramaswamy…·M. E. Grigg

This study shows TgSRS57 regulates complement deposition and Factor H recruitment on Toxoplasma gondii, promoting parasite persistence and disease tolerance.

DOI 10.1101/2022.10.17.512461

mouseproteomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintSep 9, 2022

The class XIV myosin of Toxoplasma gondii, TgMyoA, is druggable in an animal model of infection

A. Kelsen, R. S. Kent, A. K. Snyder…·G. E. Ward

This paper identifies KNX-002 as a specific inhibitor of TgMyoA, reducing parasite motility and disease progression in mice.

DOI 10.1101/2022.09.09.507210

mouseexperimental assay

𝕏 PostBluesky

BiochemistrybioRxivJul 16, 2019

Defining how oncogenic and developmental mutations of PIK3R1 alter the regulation of class IA phosphoinositide 3-kinases

G. L. Dornan, J. T. Stariha, M. K. Rathinawamy…·J. E. Burke

This study investigates how mutations in PIK3R1 affect class IA PI3K regulation, finding that oncogenic mutations hyper-activate p110 while developmental mutations reduce RTK sensitivity.

DOI 10.1016/j.str.2019.11.013

humanexperimental assay

𝕏 PostBluesky